Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ozics AG

Bone reinforcement composite for hip fractures

This article was originally published in Start Up

Executive Summary

Although standard bone cements are commonly used to treat vertebral compression fractures, these cements are not durable enough to remedy fractured hips. But a new class of biomaterials could dramatically change the landscape. Switzerland’s Ozics AG says its injectable and load-bearing implant provides an optimal level of biomechanical performance through a minimally invasive procedure.

You may also be interested in...



FDA Rejects Keytruda Dosing, Fast Tracks Tecentriq Lung Cancer Review

Keytruda is set to remain dominant despite knockback, though Tecentriq could claim prized NSCLC adjuvant approval first

Abbott Inks Automated Insulin Platform Partnership With Insulet

Abbott has signed a partnership with Insulet Corporation to create an integrated technology that automatically adjusts insulin delivery based on personalized glucose data.

EU Fast-Track Loss For Vertex’s CF Triple Combo

Vertex is hoping for EU approval in Q4 of its cystic fibrosis triple combination therapy, Trikafta. It wants the same licence in the EU as it has in the US, where the product has already become a best seller for the company.

Topics

Related Companies

UsernamePublicRestriction

Register

MT037751

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel